{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:26:50Z","timestamp":1778884010649,"version":"3.51.4"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.2169\/internalmedicine.2353-18","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T18:08:02Z","timestamp":1553710082000},"page":"1913-1916","source":"Crossref","is-referenced-by-count":2,"title":["Co-existing of Neuromyelitis Optica and Fulminant Type 1 Diabetes"],"prefix":"10.2169","volume":"58","author":[{"given":"Takanobu","family":"Saheki","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Imachi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Ibata","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Fukunaga","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Yoshioka","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seisuke","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuko","family":"Mizumoto","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuo","family":"Yoshimoto","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingya","family":"Lyu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Murao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N Engl J Med 342: 301-307, 2000.","DOI":"10.1056\/NEJM200002033420501"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Imagawa A, Hanafusa T, Uchigata Y, et al. Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care 26: 2345-2352, 2003.","DOI":"10.2337\/diacare.26.8.2345"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Imagawa A, Hanafusa T, Uchigata Y, et al. Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus. Diabetologia 48: 294-300, 2005.","DOI":"10.1007\/s00125-004-1626-x"},{"key":"4","unstructured":"4. Tsutsumi C, Imagawa A, Ikegami H, Makino H, Kobayashi T, Hanafusa T; Japan Diabetes Society Committee on Type 1 Diabetes Mellitus Research. Class II HLA genotype in fulminant type 1 diabetes: a nationwide survey with reference to glutamic acid decarboxylase antibodies. J Diabetes Investig 3: 62-69, 2012."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Liu L, Zeng L, Sang D, Lu Z, Shen J. Recent findings on fulminant type 1 diabetes. Diabetes Metab Res Rev 34: 1-7, 2018.","DOI":"10.1002\/dmrr.2928"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85: 177-189, 2015.","DOI":"10.1212\/WNL.0000000000001729"},{"key":"7","unstructured":"7. Verkman AS, Anderson MO, Papadopoulos MC. Aquaporins: important but elusive drug targets. Nat Rev Drug Discov 13: 259-277, 2014."},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Of D, Mellitus D. Diagnosis and classification of diabetes mellitus. Diabetes Care 37 (Suppl): 81-90, 2014.","DOI":"10.2337\/dc13-1041"},{"key":"9","unstructured":"9. Hanafusa T, Imagawa A. Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners. Nat Clin Pract Endocrinol Metab 3: 36-45, 2007."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Imagawa A, Hanafusa T. Fulminant type 1 diabetes-an important subtype in East Asia. Diabetes Metab Res Rev 27: 959-964, 2011.","DOI":"10.1002\/dmrr.1236"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Takeda H, Kawasaki E, Shimizu I, et al. Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study). Diabetes Care 25: 995-1001, 2002.","DOI":"10.2337\/diacare.25.6.995"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Kotani R, Nagata M, Imagawa A, et al. T lymphocyte response against pancreatic beta cell antigens in fulminant Type 1 diabetes. Diabetologia 47: 1285-1291, 2004.","DOI":"10.1007\/s00125-004-1441-4"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Lennon PVA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 364: 2106-2112, 2004.","DOI":"10.1016\/S0140-6736(04)17551-X"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hardy TA, Reddel SW, Barnett MH, Palace J, Lucchinetti CF, Weinshenker BG. Atypical inflammatory demyelinating syndromes of the CNS. Lancet Neurol 15: 967-981, 2016.","DOI":"10.1016\/S1474-4422(16)30043-6"},{"key":"15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000371492","volume":"22","author":"L Xie","year":"2015","unstructured":"15. Xie L, Long Y, Yang N, et al. No overlap among serum GAD65, NMDAR and AQP4 antibodies in patients with neuromyelitis optica spectrum disorders. Neuroimmunomodulation 22: 337-341, 2015.","journal-title":"NeuroImmunoModulation","ISSN":"https:\/\/id.crossref.org\/issn\/1021-7401","issn-type":"print"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Flanagan EP, Cabre P, Weinshenker BG, et al. Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum. Ann Neurol 79: 775-783, 2016.","DOI":"10.1002\/ana.24617"},{"key":"17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12885-018-3997-2","volume":"18","author":"Y Narumi","year":"2018","unstructured":"17. Narumi Y, Yoshida R, Minami Y, et al. Neuromyelitis optica spectrum disorder secondary to treatment with anti-PD-1 antibody nivolumab: the first report. BMC Cancer 18: 95, 2018.","journal-title":"BMC Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2407","issn-type":"print"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Barroso-Sousa R, Barry WT, Garrido-Castro AC, et al. Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens a systematic review and meta-analysis. JAMA Oncol 4: 173-178, 2018.","DOI":"10.1001\/jamaoncol.2017.3064"},{"key":"19","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.2337\/dc15-0401","volume":"38","author":"J Hughes","year":"2015","unstructured":"19. Hughes J, Vudattu N, Sznol M, et al. Precipitation of autoimmune diabetes with anti-PD-1 immunotherapy. Diabetes Care 38: e55-e57, 2015.","journal-title":"Diabetes Care","ISSN":"https:\/\/id.crossref.org\/issn\/0149-5992","issn-type":"print"},{"key":"20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/cei.12116","volume":"173","author":"F Haseda","year":"2013","unstructured":"20. Haseda F, Imagawa A, Murase-Mishiba Y, Terasaki J, Hanafusa T. CD4<sup>+<\/sup>CD45RA<sup>-<\/sup>FoxP3highactivated regulatory T cells are functionally impaired and related to residual insulin-secreting capacity in patients with type 1 diabetes. Clin Exp Immunol 173: 207-216, 2013.","journal-title":"Clinical & Experimental Immunology","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9104","issn-type":"print"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/13\/58_2353-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T23:43:19Z","timestamp":1562370199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/13\/58_2353-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":20,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2353-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,1]]}}}